Previous 10 | Next 10 |
Balchem's revenue and earnings set new historical highs for FY 2020, thanks to strong demand for human nutrition products and the company's pricing power. Accretive M&A transactions and positive news flow regarding the autism drug CM-AT are the key potential re-rating catalysts fo...
NEW HAMPTON, N.Y., April 26, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today released its 2020 Sustainability Report, which captures the Company's commitment to managing our Environmental, Social and Governance (ESG) performance. This report demonstrates the Company's cont...
NEW HAMPTON, N.Y., April 16, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, April 30 at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, CEO and President and Martin Ben...
NEW HAMPTON, N.Y., March 09, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at the J.P. Morgan Industrials Conference on March 15, 2021. Balchem...
Balchem Corporation (BCPC) Q4 2020 Earnings Conference Call February 19, 2021 11:00 AM ET Company Participants Martin Bengtsson – Chief Financial Officer Ted Harris – Chairman, Chief Executive Officer and President Conference Call Participants Mitra Ramgopal – Sidoti Stef...
Image source: The Motley Fool. Balchem Corp (NASDAQ: BCPC) Q4 2020 Earnings Call Feb 19, 2021 , 11:00 a.m. ET Operator Continue reading For further details see: Balchem Corp (BCPC) Q4 2020 Earnings Call Transcript
Balchem (BCPC): Q4 Non-GAAP EPS of $0.83 beats by $0.02; GAAP EPS of $0.68 beats by $0.03.Revenue of $180.71M (+8.5% Y/Y) beats by $5.38M.Press Release For further details see: Balchem EPS beats by $0.02, beats on revenue
NEW HAMPTON, N.Y., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today fourth quarter net earnings of $22.2 million for 2020, compared to net earnings of $20.4 million for the fourth quarter 2019. Fourth quarter adjusted net earnings (a) were $26.9 millio...
NEW HAMPTON, N.Y., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will participate in a H.C. Wainwright Fireside Chat on Wednesday, February 24, 2021. ...
Balchem delivered a good set of results for 3Q 2020, with revenue and pre-tax profit up +10.4% and +14.2% YoY, respectively. The potential FDA approval for an autism drug referred to as CM-AT in a few years' time could be a positive re-rating catalyst for Balchem in the medium term. ...
News, Short Squeeze, Breakout and More Instantly...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...
MONTVALE, N.J., July 26, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal second quarter ended June 30, 2024. The Company reported quarterly net sales of $234.1 million, quarterly net earnings of $32.1 million, adjuste...
2024-07-20 01:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...